Last update 26 Dec 2024

Daratumumab Biosimilar (Xbrane Biopharma)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Daratumumab Biosimilar (Xbrane Biopharma AB), 达雷妥尤单抗生物类似药（Xbrane Biopharma AB）, Xdarzane
Target
CD38
Mechanism
CD38 inhibitors(Lymphocyte differentiation antigen CD38 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), Antibody-dependent cellular phagocytosis (ADCP) effects
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Melanoma
Inactive Indication-
Originator Organization
Xbrane Biopharma ABXbrane Biopharma AB
Active Organization
Xbrane Biopharma ABXbrane Biopharma AB
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Daratumumab Biosimilar (Xbrane Biopharma)
Login to view more data
100 Translational Medicine associated with Daratumumab Biosimilar (Xbrane Biopharma)
Login to view more data
100 Patents (Medical) associated with Daratumumab Biosimilar (Xbrane Biopharma)
Login to view more data
100 Deals associated with Daratumumab Biosimilar (Xbrane Biopharma)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MelanomaPreclinical
SE
Xbrane Biopharma ABXbrane Biopharma AB
26 Apr 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free